Grifols (GIFLF) EBT Margin (2010 - 2025)
Grifols' (GIFLF) quarterly EBT Margin came in at 16.53% in Q4 2025, down 1.0% on a YoY basis from 16.7% in Q4 2024, and little changed quarter-over-quarter from 16.54% in Q4 2024.
Analysis
Grifols (GIFLF) EBT Margin (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported EBT Margin for 14 consecutive years, with 16.53% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 1.0% year-over-year to 16.53%; the trailing twelve-month figure through Dec 2025 stood at 17.24% (up 415.0% YoY), and the FY2025 full-year result was 8.17%, down 22201.0% from the prior year.
- EBT Margin held at 16.53% in Q4 2025 per GIFLF's latest filing, from 16.54% in the prior quarter.
- Across five years, EBT Margin topped out at 16.54% in Q4 2024 and bottomed at 485.16% in Q4 2021.
- Historically, EBT Margin has averaged 150.7% across 3 years, with a median of 16.53% in 2025.
- The sharpest annual moves came in 2021 and 2025: EBT Margin jumped 5533 bps in 2021, then dropped 1 bps in 2025.
- Over 3 years, EBT Margin stood at 485.16% in 2021, then jumped by 103 bps to 16.54% in 2024, then dropped by 0 bps to 16.53% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 16.53%, 16.54%, and 485.16% for Q4 2025, Q4 2024, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -20,427.46% |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 16.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.53% |
| Dec 31, 2024 | 16.54% |
| Dec 31, 2021 | -485.16% |
| Dec 31, 2020 | -540.49% |
| Mar 31, 2020 | 19.43% |
| Dec 31, 2019 | 14.93% |
| Mar 31, 2019 | 12.35% |
| Dec 31, 2018 | 17.92% |
| Jun 30, 2018 | 23.85% |
| Mar 31, 2018 | 17.49% |
| Dec 31, 2017 | 18.15% |
| Jun 30, 2017 | 25.22% |
| Mar 31, 2017 | 17.26% |
| Dec 31, 2016 | 1.06% |
| Sep 30, 2016 | 23.95% |
| Jun 30, 2016 | 23.32% |
| Mar 31, 2016 | 29.46% |
| Dec 31, 2015 | -2.61% |
| Sep 30, 2015 | 25.47% |
| Jun 30, 2015 | 23.62% |